We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCombining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: a potential treatment for BCR-ABL-positive leukemia.AuthorsOkabe S; Tauchi T; Kimura S; Maekawa T; Kitahara T; Tanaka Y; Ohyashiki KPublicationPloS one, 2014, Vol 9, Issue 2, pe89080ISSN1932-6203Publication typearticleDOI10.1371/journal.pone.0089080